Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Sirnaomics Ltd
2257Current price
2.9 HKD
+0.05 HKD (+1.75%)
Last closed
3.03 HKD
Company
www.sirnaomics.com
ISIN
KYG2050P1028
Sector
Healthcare
Industry
Biotechnology
Exchange
Hong Kong Stock Exchange
Capitalization
263 160 287 HKD
Yield for 12 month
-93.76 %
1Y
3Y
5Y
10Y
15Y
2257
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops product candidates for indications with medical needs. The company's therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP355 for the treatment of multiple solid tumors, including breast cancer, melanoma, and colorectal cancer; STP369 to treat head and neck and bladder cancer; STP705 for focal fat reduction; STP122G to treat coagulation disorders; STP125G to treat hypertriglyceridemia; and STP144G for the treatment of complement diseases. In addition, it is developing RV-1730, a Covid-19 vaccine; RV-1770, a respiratory syncytial virus vaccine; STP247G, STP144G, STP145G, and STP146G for the treatment of complement diseases; STP152G for ATTR amyloidosis indication; STP136G to treat hypertension; STP251G for treating hemochromatosis and hypertriglyceridemia; and STP237G to treat hypertension and hypertriglyceridemia. The company was founded in 2007 and is based in Wan Chai, Hong Kong. Address: Hopewell Centre, Wan Chai, Hong Kong
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
558.59 HKDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures 2257
1 year
3 years
5 years
10 years
EBITDA
-53 196 982 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-46.84 %
PEG Ratio
–
Return On Equity TTM
-342.57 %
Wall Street Target Price
558.59 HKD
Revenue TTM
1 078 446 HKD
Book Value
0.003 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
297.4 %
Dividend Yield
–
Gross Profit TTM
26 011 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2257
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2257
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2257
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
241.6021
Enterprise Value EBITDA
-15.8377
Price Book MRQ
138.6383
Financials 2257
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2257
For 52 weeks
2.49 HKD
48.97 HKD
50 Day MA
3.27 HKD
Shares Short Prior Month
–
200 Day MA
8.65 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart